FDA Inspection 1274273 — New Zealand Pharmaceutical Ltd.
The FDA completed an inspection of New Zealand Pharmaceutical Ltd. on May 16, 2025 in Palmerston North. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Palmerston North (New Zealand)